Diffusion MRI for prediction of response of rectal cancer to chemoradiation

Lancet. 2002 Jul 27;360(9329):307-8. doi: 10.1016/S0140-6736(02)09520-X.

Abstract

Prediction of tumour response before onset of treatment could have considerable clinical benefit. Since the apparent diffusion coefficient (ADC) of a tumour's water content can show the extent of necrosis, we looked for a possible correlation of ADC with response to treatment. We measured mean tumour water ADC before and after chemotherapy and chemoradiation in 14 patients with locally advanced rectal cancer, with a quantitative magnetic resonance diffusion imaging sequence. We found a strong negative correlation between mean pretreatment tumour water ADC and percentage size change of tumours after chemotherapy (r=-0.67, p=0.01) and chemoradiation (r=-0.83, p=0.001). Persistence of low ADC in responders after chemotherapy could represent loss of a non-viable fraction of the treated tumour.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / radiotherapy
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Body Water / drug effects
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Rectal Neoplasms / drug therapy*
  • Rectal Neoplasms / radiotherapy
  • Treatment Outcome

Substances

  • Antineoplastic Agents